Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25

Cancer Science

Volumn 98, Issue 7, 2007, Pages 1055-1063

  Sato, Yuichiro ^a   Chen, Zhaoxin ^a   Miyazaki, Kaoru ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INSULIN; KALININ; MAC25 PROTEIN; SMALL INTERFERING RNA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN RELATED PROTEIN 1; TUMOR DERIVED CELL ADHESION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENICITY; CELL ADHESION; CELL AGING; CELL SURFACE; COLON ADENOCARCINOMA; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; APOPTOSIS; BREAST NEOPLASMS; CELL ADHESION; CELL DIVISION; CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; PROSTATIC NEOPLASMS; TRANSFECTION; URINARY BLADDER NEOPLASMS;

EID: 34249886583     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00502.x     Document Type: Article

References (38)

1. Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999; 20: 761-87.
2. Burger AM, Leyland-Jones B, Banerjee K, Spyropoulos DD, Seth AK. Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer. Eur J Cancer 2005; 41: 1515-27.
3. Rechler MM. Insulin-like growth factor binding proteins. Vitam Horm Rev 1993; 47: 1-114.
4. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocrinol Rev 1995; 16: 3-34.
5. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7: Recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem 1996; 271: 30.322-5.
6. Akaogi K, Sato J, Okabe Y, Sakamoto Y, Yasumitsu H, Miyazaki K. Synergistic growth stimulation of mouse fibroblasts by tumor-derived adhesion factor with insulin-like growth factors and insulin. Cell Growth Differ 1996; 7: 1671-7.
7. Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H. Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J 1994; 303: 591-8.
8. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL. Identification and characterization of genes differently expressed in meningiomas. Cell Growth Differ 1993; 4: 715-22.
9. Akaogi K, Okabe Y, Funahashi K et al. Cell adhesion activity of a 30-kDa major secreted protein from human bladder carcinoma cells. Biochem Biophys Res Commun 1994; 198: 1046-53.
10. Akaogi K, Okabe Y, Sato J et al. Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc Natl Acad Sci USA 1996; 93: 8384-9.
11. Sato J, Hasegawa S, Akaogi K et al. Identification of cell-binding site of angiomodulin (AGM/TAF/Mac25) that interacts with heparan sulfates on cell surface. J Cell Biochem 1999; 75: 187-95.
12. Kishibe J, Yamada S, Okada Y et al. Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/ angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells. J Biol Chem 2000; 275: 15.321-9.
13. Ahmed S, Yamamoto K, Sato Y et al. Proteolytic processing of IGFBP-related protein-1 (TAF/angiomodulin/mac25) modulates its biological activity. Biochem Biophys Res Commun 2003; 310: 612-18.
14. Adachi Y, Itoh F, Yamamoto H et al. Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer. Int J Cancer 2001; 95: 216-22.
15. Degeorges A, Wang F, Frierson HF Jr, Seth A, Sikes RA. Distribution of IGFBP-rP1 in normal human tissues. J Histochem Cytochem 2000; 48: 747-54.
16. Swisshelm K, Ryan K, Tsuchiya K, Sager R. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci USA 1995; 92: 4472-6.
17. Komatsu S, Okazaki Y, Tateno M et al. Methylation and downregulated expression of mac25/insulin-like growth factor binding protein-7 is associated with liver tumorigenesis in SV40T/t antigen transgenic mice, screened by restriction landmark genomic scanning for methylation (RLGS-M). Biochem Biophys Res Commun 2000; 267: 109-17.
18. Wilson HM, Birnbaum RS, Poot M, Quinn LS, Swisshelm K. Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. Cell Growth Differ 2002; 13: 205-13.
19. Burger AM, Zhang X, Li H et al. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene 1998; 16: 2459-67.
20. Hwa V, Tomasini-Sprenger C, Bermejo AL, Rosenfeld RG, Plymate SR. Characterization of insulin-like growth factor-binding protein-related protein-1 in prostate cells. J Clin Endocrinol Metab 1998; 83: 4355-62.
21. Sprenger CC, Damon SE, Hwa V, Rosenfeld RG, Plymate SR. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer. Cancer Res 1999; 59: 2370-5.
22. Sprenger CC, Vail ME, Evans K, Simurdak J, Plymate SR. Over-expression of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis. Oncogene 2002; 21: 140-7.
23. Kato MV. A secreted tumour-suppressor, mac25, with activin-binding activity. Mol Med 2000; 6: 126-35.
24. Kariya Y, Ishida K, Tsubota Y et al. Efficient expression system of human recombinant laminin-5. J Biochem 2004; 132: 607-12.
25. Hirosaki T, Mizushima H, Tsubota Y, Moriyama K, Miyazaki K. Structural requirement of carboxyl-terminal globular domains of laminin alpha 3 chain for promotion of rapid cell adhesion and migration by laminin-5. J Biol Chem 2000; 275: 22.495-502.
26. Ahmed S, Jin X, Yagi M et al. Identification of membrane-bound serine proteinase matriptase as a processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25). FEBS J 2006; 273: 615-27.
27. Mutaguchi K, Yasumoto H, Mita K et al. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer. Cancer Res 2003; 63: 7717-23.
28. Chen Y, Pacyna-Genqelbach M, Ye F et al. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer. J Pathol 2007; 211: 431-8.
29. Guo W, Giancotti FG. Integrin signaling during tumor progression. Nat Rev Mol Cell Biol 2004; 5: 816-26.
30. Yamada KM, Even-Ram S. Integrin regulation of growth factor receptors. Nat Cell Biol 2002; 4: E75-6.
31. Umeda F, Ono Y, Sekiguchi N et al. Increased mRNA expression of a novel prostacyclin-stimulating factor in human colon cancer. J Gastroenterol 1998; 33: 213-17.
32. Usui T, Murai T, Tanaka T et al. Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells. Int Immunol 2002; 14: 1273-82.
33. Nagakubo D, Murai T, Tanaka T et al. A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines. J Immunol 2003; 171: 553-61.
34. Salahifar H, Firth SM, Baxter RC, Martin JL. Characterization of an amino-terminal fragment of insulin-like growth factor binding protein-3 and its effects in MCF-7 breast cancer cells. Growth Horm IGF Res 2000; 10: 367-77.
35. Leal SM, Huang SS, Huang JS. Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-β receptor in mink lung epithelial cells. J Biol Chem 1999; 274: 6711-17.
36. Schedlich LJ, Young TF, Firth SM, Baxter RC. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 1998; 273: 18.347-52.
37. Diehl D, Hoeflich A, Wolf E, Lahm H. Insulin-like growth factor (IGF)-binding protein-4 inhibits colony formation of colorectal cancer cells by IGF-independent mechanisms. Cancer Res 2004; 64: 1600-3.
38. Yamanaka Y, Wilson EM, Rosenfeld RG, Oh Y. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem 1997; 272: 30.729-34.